Théa and Tsubota enter into Licensing Agreement

Tsubota Laboratory, Inc. is a Japanese laboratory focused on research and development related to the prevention and treatment of myopia, dry eye, presbyopia and other ocular and systemic diseases.

 

On Thursday, December 22, Thea announced that it has recently entered into an exclusive license agreement for the development, manufacture and commercialization of TLM-003.

 

LM-003 is a new type of eye drop for the prevention of myopia progression. This eye drop inhibits scleral thinning, thereby reducing scleral stretching and myopia.